Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00627_DB00930_nanopub.RAWpiRJaIrcDGYrVKFewwncocNFVKYuScWK1iGjkgfVM8#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00627_DB00930 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00627_DB00930 label "DDI between Niacin and Colesevelam - Bile Acid Sequestrants may decrease the absorption of Niacin. It may be prudent to separate the administration times of niacin and bile acid sequestrants by a few hours in order to reduce the potential for reduced efficacy of these agents. The manufacturer of colesevelam recommends that drugs should be administered at least 1 hour before or 4 hours after colesevelam. [drugbank_resource:DB00627_DB00930]" assertion.
- drugbank_resource:DB00627_DB00930 identifier "drugbank_resource:DB00627_DB00930" assertion.
- drugbank_resource:DB00627_DB00930 title "DDI between Niacin and Colesevelam - Bile Acid Sequestrants may decrease the absorption of Niacin. It may be prudent to separate the administration times of niacin and bile acid sequestrants by a few hours in order to reduce the potential for reduced efficacy of these agents. The manufacturer of colesevelam recommends that drugs should be administered at least 1 hour before or 4 hours after colesevelam." assertion.
- drugbank:DB00930 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00627_DB00930 assertion.
- drugbank:DB00627 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00627_DB00930 assertion.